374 related articles for article (PubMed ID: 26974272)
1. Post-bone marrow transplant thrombotic microangiopathy.
Obut F; Kasinath V; Abdi R
Bone Marrow Transplant; 2016 Jul; 51(7):891-7. PubMed ID: 26974272
[TBL] [Abstract][Full Text] [Related]
2. Renal dysfunction following bone marrow transplantation.
Kemmner S; Verbeek M; Heemann U
J Nephrol; 2017 Apr; 30(2):201-209. PubMed ID: 27589851
[TBL] [Abstract][Full Text] [Related]
3. Emerging Concepts in Hematopoietic Stem Cell Transplantation-Associated Renal Thrombotic Microangiopathy and Prospects for New Treatments.
Wanchoo R; Bayer RL; Bassil C; Jhaveri KD
Am J Kidney Dis; 2018 Dec; 72(6):857-865. PubMed ID: 30146419
[TBL] [Abstract][Full Text] [Related]
4. [Transplantation-associated thrombotic microangiopathy confirmed by renal biopsy].
Miyamoto S; Kimura S; Hosoya Y; Hasegawa D; Ishida H; Daida A; Matsui T; Yoshimoto Y; Hirabayashi S; Fujimaru T; Kumamoto T; Mori SI; Suzuki K; Manabe A
Rinsho Ketsueki; 2018; 59(4):389-394. PubMed ID: 29743397
[TBL] [Abstract][Full Text] [Related]
5. Transplant-Associated Thrombotic Microangiopathy in the Context of Allogenic Hematopoietic Stem Cell Transplantation: Where We Stand.
Lazana I
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674666
[TBL] [Abstract][Full Text] [Related]
6. Renal Thrombotic Microangiopathy: A Review.
Genest DS; Patriquin CJ; Licht C; John R; Reich HN
Am J Kidney Dis; 2023 May; 81(5):591-605. PubMed ID: 36509342
[TBL] [Abstract][Full Text] [Related]
7. A review of thrombotic microangiopathies in multiple myeloma.
Portuguese AJ; Gleber C; Passero FC; Lipe B
Leuk Res; 2019 Oct; 85():106195. PubMed ID: 31404728
[TBL] [Abstract][Full Text] [Related]
8. A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury.
Jodele S; Laskin BL; Dandoy CE; Myers KC; El-Bietar J; Davies SM; Goebel J; Dixon BP
Blood Rev; 2015 May; 29(3):191-204. PubMed ID: 25483393
[TBL] [Abstract][Full Text] [Related]
9. Complement in Pathophysiology and Treatment of Transplant-Associated Thrombotic Microangiopathies.
Jodele S
Semin Hematol; 2018 Jul; 55(3):159-166. PubMed ID: 30032753
[TBL] [Abstract][Full Text] [Related]
10. Case Report: Successful Treatment With Anti-C5 Monoclonal Antibody in a Japanese Adolescent Who Developed Thrombotic Microangiopathy After Autologous Bone Marrow Transplantation for Malignant Lymphoma.
Shimizu S; Morohashi T; Kanezawa K; Yagasaki H; Takahashi S; Morioka I
Front Pediatr; 2022; 10():908183. PubMed ID: 35859949
[TBL] [Abstract][Full Text] [Related]
11. [Management of transplant-associated thrombotic microangiopathy].
Ikezoe T
Rinsho Ketsueki; 2018; 59(10):2307-2314. PubMed ID: 30305540
[TBL] [Abstract][Full Text] [Related]
12. Transplant-associated thrombotic microangiopathy: elucidating prevention strategies and identifying high-risk patients.
Jodele S; Sabulski A
Expert Rev Hematol; 2021 Aug; 14(8):751-763. PubMed ID: 34301169
[TBL] [Abstract][Full Text] [Related]
13. Spectrum of complement-mediated thrombotic microangiopathies: pathogenetic insights identifying novel treatment approaches.
Riedl M; Fakhouri F; Le Quintrec M; Noone DG; Jungraithmayr TC; Fremeaux-Bacchi V; Licht C
Semin Thromb Hemost; 2014 Jun; 40(4):444-64. PubMed ID: 24911558
[TBL] [Abstract][Full Text] [Related]
14. Thrombotic microangiopathy following bone marrow transplantation.
Pettitt AR; Clark RE
Bone Marrow Transplant; 1994 Oct; 14(4):495-504. PubMed ID: 7858524
[TBL] [Abstract][Full Text] [Related]
15. Transplantation-Associated Thrombotic Microangiopathy Risk Stratification: Is There a Window of Opportunity to Improve Outcomes?
Jodele S; Dandoy CE; Sabulski A; Koo J; Lane A; Myers KC; Wallace G; Chima RS; Teusink-Cross A; Hirsch R; Ryan TD; Benoit S; Davies SM
Transplant Cell Ther; 2022 Jul; 28(7):392.e1-392.e9. PubMed ID: 35490975
[TBL] [Abstract][Full Text] [Related]
16. Refractory secondary thrombotic microangiopathy with kidney injury associated with systemic lupus erythematosus in a pediatric patient.
Kaneda T; Tanaka E; Akutsu Y; Kanamori T; Mouri M; Morio T; Mori M
CEN Case Rep; 2020 Nov; 9(4):301-307. PubMed ID: 32304042
[TBL] [Abstract][Full Text] [Related]
17. Early Increase in Complement Terminal Pathway Activation Marker sC5b-9 Is Predictive for the Development of Thrombotic Microangiopathy after Stem Cell Transplantation.
Horváth O; Kállay K; Csuka D; Mező B; Sinkovits G; Kassa C; Stréhn A; Csordás K; Sinkó J; Prohászka Z; Kriván G
Biol Blood Marrow Transplant; 2018 May; 24(5):989-996. PubMed ID: 29339271
[TBL] [Abstract][Full Text] [Related]
18. Reeling in complement in transplant-associated thrombotic microangiopathy: You're going to need a bigger boat.
Jodele S; Sabulski A
Am J Hematol; 2023 May; 98 Suppl 4():S57-S73. PubMed ID: 36746623
[TBL] [Abstract][Full Text] [Related]
19. Complement activation and blockade in massive post-partum haemorrhage, thrombotic microangiopathy and acute kidney injury: a case report.
Guzzo G; Kissling S; Pantaleo G; Pascual M; Sadallah S; Teta D
BMC Nephrol; 2021 Jul; 22(1):252. PubMed ID: 34229609
[TBL] [Abstract][Full Text] [Related]
20. Two cases of kidney transplantation-associated thrombotic microangiopathy successfully treated with eculizumab.
Ikeda T; Okumi M; Unagami K; Kanzawa T; Sawada A; Kawanishi K; Omoto K; Ishida H; Tanabe K
Nephrology (Carlton); 2016 Jul; 21 Suppl 1():35-40. PubMed ID: 26970541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
